← Back to headlines
Biotech Company Faces FDA Catalyst as Fund Cuts Stake
A biotech company is approaching a June 30 FDA catalyst, prompting a fund to reduce its stake by $7 million.
17 May, 18:52 — 17 May, 18:52
Sources
Showing 1 of 1 sources
A biotech company is approaching a June 30 FDA catalyst, prompting a fund to reduce its stake by $7 million.
